Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dapagliflozin (farxiga) (1 trial)
remd-477 (6 trials)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Trials (6 total)
Trial APIs (2 total)